These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 20547101)
1. Immunotherapeutic strategies to combat staphylococcal infections. Ohlsen K; Lorenz U Int J Med Microbiol; 2010 Aug; 300(6):402-10. PubMed ID: 20547101 [TBL] [Abstract][Full Text] [Related]
2. MSCRAMM--targeted vaccines and immunotherapy for staphylococcal infection. Rivas JM; Speziale P; Patti JM; Höök M Curr Opin Drug Discov Devel; 2004 Mar; 7(2):223-7. PubMed ID: 15603256 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapeutic approaches against Staphylococcus aureus. Verkaik NJ; van Wamel WJ; van Belkum A Immunotherapy; 2011 Sep; 3(9):1063-73. PubMed ID: 21913829 [TBL] [Abstract][Full Text] [Related]
4. Novel targets for antibiotics in Staphylococcus aureus. Ohlsen K; Lorenz U Future Microbiol; 2007 Dec; 2(6):655-66. PubMed ID: 18041906 [TBL] [Abstract][Full Text] [Related]
5. Anti-Staphylococcus aureus immunotherapy: current status and prospects. García-Lara J; Foster SJ Curr Opin Pharmacol; 2009 Oct; 9(5):552-7. PubMed ID: 19733119 [TBL] [Abstract][Full Text] [Related]
6. Vaccination and passive immunisation against Staphylococcus aureus. Schaffer AC; Lee JC Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S71-8. PubMed ID: 18757184 [TBL] [Abstract][Full Text] [Related]
7. Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines. Broughan J; Anderson R; Anderson AS Expert Rev Vaccines; 2011 May; 10(5):695-708. PubMed ID: 21604989 [TBL] [Abstract][Full Text] [Related]
8. Staphylococcal vaccines and immunotherapy: to dream the impossible dream? Projan SJ; Nesin M; Dunman PM Curr Opin Pharmacol; 2006 Oct; 6(5):473-9. PubMed ID: 16870507 [TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus pneumonia: emergence of MRSA in the community. Bradley SF Semin Respir Crit Care Med; 2005 Dec; 26(6):643-9. PubMed ID: 16388433 [TBL] [Abstract][Full Text] [Related]
17. Targeted immunotherapy for staphylococcal infections : focus on anti-MSCRAMM antibodies. Otto M BioDrugs; 2008; 22(1):27-36. PubMed ID: 18215088 [TBL] [Abstract][Full Text] [Related]
18. Clinical isolates of Staphylococcus aureus from the Arkhangelsk region, Russia: antimicrobial susceptibility, molecular epidemiology, and distribution of Panton-Valentine leukocidin genes. Vorobieva V; Bazhukova T; Hanssen AM; Caugant DA; Semenova N; Haldorsen BC; Simonsen GS; Sundsfjord A APMIS; 2008 Oct; 116(10):877-87. PubMed ID: 19132981 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology, clinical features and management of infections due to community methicillin-resistant Staphylococcus aureus (cMRSA). Gosbell IB Intern Med J; 2005 Dec; 35 Suppl 2():S120-35. PubMed ID: 16271056 [TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED. Viallon A; Marjollet O; Berthelot P; Carricajo A; Guyomarc'h S; Robert F; Zeni F; Bertrand JC Am J Emerg Med; 2007 Oct; 25(8):880-6. PubMed ID: 17920971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]